#GOACON #Rajkot
We Smit Medimed, Manufacturer & Exporter of the Orthopaedic Implants & Instruments.
We participated in GOACON 2020 Event held in Rajkot< Gujarat from 8th & 9th Feb, 2020.
We exhibited our Spinal Implants, Trauma implants, Intramedullary nailing system & Hip & Knee Replacement system and instruments.
#ArabHealth #Dubai
We Smit Medimed, Manufacturer & Exporter of the Orthopaedic Implants & Instruments.
We are very glad to invite you to visit our Booth No.R. P75 at ARAB HEALTH from 27th to 30th January, 2020 at Dubai World Trade Centre, Dubai.
We will be presenting our all products range of Trauma Implants, Spine Implants, Joints Replacement System, Intramedullary Nailing System& High Quality of Orthopaedic Instruments.
Your presence will do us great honor and we are looking forward to seeing you. Hope to see you there
#IOACON2019
We participated in IOACON 2019 Event held at Biswa Bangla Convention Centre Kolkata, West Bengal from 19th to 24th November , 2019.
We exhibited our Spinal Implants, Trauma implants, Intramedullary nailing system, Hip & Knee Replacement system and instruments.
VOSCON 2019
We participated in VOSCON 2019 Event held at City Sports Club(CSC) resort, NH-6, Amravti Road, Akola on 19th & 20th October 2019.
We exhibited our Spinal Implants, Trauma Implants, Intramedullary Nailing system, Hip & Knee Replacement System and instruments.
Expo Medical is the largest professional event for the entire Health Sector in Argentina and the Spanish-speaking countries. It is a regional South American exhibition that acts as a great meeting point between supply and demand, in an area that encourages personal interaction, technological updating and business concretion. For know about Expo medical click below link expomedical.com
We participated in Expo Medical 2019 Event held in Buenos Aires, Argentina from 25th to 27th September, 2019.
We exhibited our Trauma Implants, Spine Implants, Intramedullary Nail System, Total Hip & Knee Replacement System & High Quality of Orthopaedic Instruments.
Anterior cervical discectomy and fusion (ACDF) is a surgical procedure to treat nerve root or spinal cord compression by decompressing the spinal cord and nerve roots of the cervical spine with a discectomy, followed by inter-vertebral fusion to stabilize the corresponding vertebrae.This procedure is used when other non-surgical treatments have failed.
ACDF is used to treat serious pain from a nerve root that has become inflamed. This can be caused by:
1. a herniated disc when other non-surgical treatments have failed. The nucleus pulposus (the jelly-like center of the disc) of the herniated disc bulges out through the annulus (surrounding wall) and presses on the nerve root next to it.
2. degenerative disc disease (spondylosis). The disc consists of about 80% water. When one grows older, the disc starts to dry out and shrink, causing small tears in the annulus and inflammation of the nerve root.
The neurosurgeon or orthopedic surgeon enters the space between two discs through a small incision in front (= anterior) of and at the right or left side of the neck. The disc is completely removed, as well as arthritic bone spurs. The disc material, pressing on the spinal nerve or spinal cord, is then completely removed. The intervertebral foramen, the bone channel through which the spinal nerve runs, is then enlarged with a drill giving the nerve more room to exit the spinal canal.
To prevent the vertebrae from collapsing and to increase stability, the open space is often filled with a graft. That can be a bone graft, taken from the pelvis or cadaveric bone; or an artificial implant. The slow process of the bone graft joining the vertebrae together is called “fusion”. Sometimes a titanium plate is screwed on the vertebrae or screws are used between the vertebrae to increase stability during fusion, especially when there is more than one disc involved.
The surgery requires a short stay in the clinic (1 to 3 days) and a gradual recovery between 1 and 6 weeks. However, the technology has advanced and it can be performed by ‘Endoscopic Micro Discectomy” with the patient able to continue their normal life in two days. The patient may be advised to wear a neck brace or collar (for up to 8 weeks) that serves to ensure proper spinal alignment. Wearing the brace heightens one’s awareness of posture and positioning and helps prevent movements (e.g., sudden and/or excessive bending or twisting of the neck) that may aggravate or slow down the healing process.
It is especially advisable to wear a protective neck brace when traveling (e.g., by car), sleeping, showering, or any other activities in which the patient may not be able to be ensure proper spinal alignment. In addition, physical therapy and related healing modalities (e.g., massage, acupuncture) may be recommended in order to promote proper healing, as well as to strengthen the surrounding muscles that can take over the neck brace’s ‘job’ of ensuring proper spinal alignment when the patient starts (around 4 to 6 weeks after surgery) to wean off the neck brace.
Article From : wikipedia.com
Spine surgery has advanced dramatically with the technology surrounding minimally invasive surgical (MIS) techniques. Surgical materials, nerve monitoring, and computer-aided navigation have improved significantly recently. With these techniques, the risks, recovery time, and surgical complications have decreased greatly.
For some patients who have spinal instability or have been recommended spinal fusion, it is important to understand what minimally invasive options may be available.
Advances in spine imaging, such as MRI, allow surgeons to see smaller and smaller spinal problems. Individual spinal nerves, bone spurs, and small disc fragments can be easily seen and diagnosed. Similarly, spinal surgery techniques have advanced to the point where some procedures involve incisions less than 1 inch.
Many modern techniques can be described as “minimally invasive” surgery, or “MIS.” For some patients, a minimally invasive procedure may be a better surgical option than a traditional or “open” spinal surgery. Instead of removing muscle attachments from bones, a minimally invasive surgery spreads and pushes muscles out of the way.
X-rays, computer-aided navigation techniques, and specialized tubes or retractors with special cameras or microscopes have led to major advances in the capabilities of MIS surgery. In addition to a smaller incision, MIS surgery has several advantages. It has been shown, on average, to cause decreases in blood loss, post-operative pain and narcotic use, soft tissue damage, and number of days spent in the hospital. On average, patients have a faster recovery, and return to normal activity and work faster.
Procedures to decompress nerves of the spine include removing: herniated discs, enlarged ligaments and soft tissue, and bone spurs that are pressing on spinal nerves. In some cases, motion of the spine may become unstable or painful, either from wear and tear, trauma, or from a decompression procedure. These patients may be offered spinal fusion. There are MIS options and techniques available for both types of spinal surgery.
A normal spinal canal is filled with fluid that surrounds the spinal cord and nerves. As the spine degenerates, spinal joints get bigger (just like the knuckles on our fingers), and discs may collapse or bulge. As this happens, room for the spinal cord and roots decreases and this may lead to pain or weakness in the legs. In severe cases, a minimally invasive surgical procedure may not be an option, and an “open” procedure may be the best choice to remove arthritic bone spurs. However, for some patients where spinal stenosis is in only 1 or 2 levels, a minimally invasive surgery may be a better option with a quicker recovery.
Bone spurs and arthritis is removed from the spine where nerves are compressed using a tube or retractor that is often less than an inch in diameter. A high-powered surgical microscope is used through the tube so that the nerves can be safely seen and protected throughout the operation. This smaller incision, less muscle disruption, and preservation of more of the patient’s anatomy may lead to a quicker recovery, and physical therapy can begin sooner.
Spinal fusion is always a major undertaking, and any patient considering it should understand the risks and recovery involved. Damage to nerves, infection, failure of bones to fuse properly, or the need for more surgery is all included in the risks of a minimally invasive or traditional “open” surgery. For this reason, it is important that patients consider and fail all possible non-surgical or “conservative” methods with their surgeon before making the decision to undergo spine surgery. These non-surgical treatments include physical therapy, heat/ice, anti-inflammatory or neurologic-acting medication, bracing, or spinal injections before surgery.
Instrumentation used to fuse vertebrae together is placed under x-ray guidance through small and specialized retractors, with an incision about an inch and a half or less in length. Through the same retractors, bone spurs are removed, and spinal nerves are decompressed using a high-powered surgical microscope. For these patients, a smaller incision and less muscle disruption may lead to a quicker recovery and less post-operative pain.
When spine surgery is recommended, it is important for patients to discuss minimally invasive options with their surgeon.
Minimally invasive surgery, or “MIS,” is not the right option for all patients. It is important to understand why you may not be a candidate for MIS. Some surgeons have not been trained using these techniques, and do not offer them even though their patients may benefit. Before undergoing a spinal surgery, you should have a good understanding of the procedure itself and what to expect during the recovery process. Since pain and recovery are personal and individualized for each patient, no surgeon can guarantee a particular recovery course. However, for many patients, an MIS option may result in a smoother and more successful outcome.
Platelet-rich plasma (PRP) is a concentrate of autologous blood growth factors which has been shown to provide some symptomatic relief in early osteoarthritis (OA) of the knee. Platelet-rich plasma therapy is a simple and minimally invasive intervention which is feasible to deliver in primary care to treat osteoarthritis of the knee joint.
Researchers ascertained if patient satisfaction with platelet-rich plasma (PRP) therapy was correlated with the degree of cartilage damage quantified with magnetic resonance imaging (MRI). A pre-treatment MRI was performed and analyzed according to Peterfy and colleagues by a senior consultant radiologist with the whole-organ MRI scoring method (WORMS) to assess the level of osteoarthritis. They performed PRP in 59 patients using a low-leukocyte autologous conditioned plasma system. Findings suggested that intraarticular injection of PRP may improve symptoms of osteoarthritis and decrease pain in patients with knee joint osteoarthritis regardless of the level of cartilage damage quantified by the whole-organ MRI scoring method WORMS.
Credit to : www.mdlinx.com
Increasing prevalence of chronic diseases and rising awareness regarding personal care will drive future growth.
The global 3D printed medical devices market is expected to expand at a compound annual growth rate (CAGR) of 18.1 percent through 2027. An increasing prevalence of chronic diseases and rising awareness regarding personal care are major factors twill drive growth of the market during this period, according to Future Market Insights.
Increased Ability to Innovate Aids the Global 3D Printed Medical Devices Market
With increasing popularity of 3D printing, medical devices manufacturers are particularly focused on innovations. Substantial need for individualized yet economical medical solutions is met through 3D printing. Complex features of integration such as hard and soft areas, solid and porous structures, multi-material and multi-color, which seemed to be difficult by implementing conventional manufacturing techniques, is made simpler through 3D printing. Patient-specific implants are being manufactured based on computed tomography (CT) and magnetic resonance imaging (MRI) scans provided by surgeons, which results in reduction of the overall surgical cost. This has increased the popularity of 3D printed medical devices all around the world.
The global 3D printed medical devices market is segmented based on application, technology, material type, end user and region. On the basis of application, the market has been segmented into orthopedic Implants, dental implants and cranio-maxillofacial implants. Orthopedic implants application segment accounted for a higher revenue share in global 3D printing devices as compared to others in application segment. Orthopedic implants segment in the application category of the global 3D printed medical devices market was estimated to be valued at nearly $170 million in 2017 and is slated to reach a valuation of nearly $970 million in 2027, exhibiting a 19.2 percent CAGR during the period of assessment.
Based on the material type, 3D printed medical devices market is segmented into metals and alloys, biomaterial inks and plastics. The biomaterial inks segment was estimated to be valued at nearly $65 million in 2017 and is anticipated to reach a valuation of nearly $400 million in 2027, displaying a CAGR of 20 percent during the period of forecast.
Based on the end user, 3D printed medical devices market is segmented into hospitals, ambulatory surgical centres and diagnostic centres. Hospital end user segment accounts for higher demand for 3D printing devices as compared to other distribution channel segments such as ambulatory surgical centres and diagnostic centres, registering a CAGR of 18.7 percent over the forecast period.
On the basis of region, the global 3D printed medical devices market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East and Africa. Revenues in Western Europe are expected to grow at a CAGR of 18.6 percent, whereas Eastern Europe is anticipated to grow at 15.5 percent over the forecast period. The Western Europe 3D printed medical devices market was estimated to be valued at nearly $65 million in 2017 and is slated to reach a value of nearly $360 million in 2027. The Eastern Europe 3D printed medical devices market was estimated to be valued at nearly $40 million in 2017 and is anticipated to reach a value of nearly $160 millin in 2027.
Some of the players in the global 3D printed medical devices market include 3D Systems Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K. and Formlabs Inc., among others. Key players are focusing on strengthening their position by establishing new facilities in North America region. Moreover, companies are targeting Asia-Pacific region and Europe by distribution agreements with local players. In order to increase their revenue, major players in the North America region are entering into agreements with hospitals and academic institutes.
Future Market Insights provides market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London and has delivery centers in the United States and India.
From : www.odtmag.com
This study proposed to access the clinical outcome of avulsion fractures around joints of extremities using the hook plate.
A total of 60 patients with avulsion fractures of joints admitted in their hospital between January 2011 and June 2016 were performed the surgery of hook plate fixation. Functional recovery was evaluated using the Lysholm knee score, Kaikkonen ankle injury score, Mayo elbow and wrist function score, and Neer shoulder function score.
All the patients were healed within 3 months after surgery with stage They healing incision without vascular or nerve injuries. The average follow-up period was 18.1 months. At the last follow-up, no instability of joints, looseness of internal fixation or traumatic arthritis was observed. Mild joint fibrosis occurred in 5 cases. A total of 57 patients were well recovered with the excellent and good rate of 95%. Three patients with humeral avulsion fracture of the greater tuberosity had shoulder joint adhesion and peri humeral inflammation at the last follow-up due to the poor cooperation for early rehabilitation exercise. In the last follow-ups, the functional score of the affected limb was markedly greater than that in the 3-month follow-ups (p < 0.05).
Hook plate fixation has the therapeutic effect on treating avulsion fractures around joints of extremities with the advantages of reliable fixation, early rehabilitation after operation, high recovery rates of joint function, wide indications, and convenient uses.
Copyright : MDLinx.com
We offer a wide variety of safe and advanced Orthopedic Implants and fixators. At the helm of the company’s operations is Mr. Vinodbhai, the Director. His enterprising skills and experience in the industry continue to play a pivotal role in the company’s growth.We are based in Ahmedabad city West Part of India.
Plot No.10, Phase-1, B|h. Prashant Eng., G.I.D.C.Vatva, Ahmedabad-382 445, Gujarat, (INDIA).